chronic lymphocytic leukemia associated with marked clinical efficacy in refractory, genetically high-risk Flavopiridol administered using a pharmacologically derived schedule is
2010
- Correction
- Cite
- Save
- Machine Reading By IdeaReader
36
References
0
Citations
NaN
KQI